phosphatidylcholines has been researched along with 2019 Novel Coronavirus Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 11 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babincak, M; Kiskova, T; Kolesarova, M; Kostolny, J; Kukelova, D; Leskanicova, A; Macekova, D; Mochnacky, F; Pipova Kokosova, N; Urbanska, N | 1 |
| Cai, JP; Cao, J; Chan, CC; Chan, JF; Chan, KH; Chik, KK; Chu, H; Chung, TW; Fung, K; Hung, IF; Jin, DY; Kao, RY; Lai, PM; Luo, C; Qin, Z; Sze, KH; Tam, AR; Tsang, JO; Xie, Y; Yan, B; Ye, ZW; Yin, F; Yuan, S; Yuen, KY; Yuen, TT; Zou, Z | 1 |
| Aoki, J; Doi, K; Harada, S; Hashimoto, H; Jubishi, D; Kano, K; Kurano, M; Moriya, K; Okamoto, K; Okugawa, S; Saigusa, D; Sakai, E; Yatomi, Y | 1 |
| Baršić, B; Kmet, M; Lukšić, I; Orehovec, B; Skrzydlewska, E; Tarle, M; Tatzber, F; Wonisch, W; Žarković, N; Łuczaj, W | 1 |
| Aoki, J; Doi, K; Harada, S; Hashimoto, H; Jubishi, D; Kano, K; Kurano, M; Morita, Y; Moriya, K; Okamoto, K; Okugawa, S; Saigusa, D; Sakai, E; Yatomi, Y | 1 |
| Ermilova, I; Swenson, J | 1 |
| Butcher, NJ; Kaminskas, LM; Minchin, RF; Subasic, CN | 1 |
| Amede, E; Baldanzi, G; Barberis, E; Cappellano, G; Casciaro, FG; Chiocchetti, A; Cittone, MG; Dianzani, U; Falasca, M; Galbiati, A; Hayden, E; Manfredi, M; Marengo, E; Nerici, I; Pedrinelli, AR; Priora, S; Puricelli, C; Raineri, D; Rizzi, E; Rolla, R; Sainaghi, PP; Timo, S; Vanella, VV; Vaschetto, R; Vassia, V | 1 |
| Bizzarri, M; Garzon, S; Laganà, AS; Unfer, V | 1 |
| Bhattacharjya, S; Chakraborty, H; Pattnaik, GP | 1 |
| Capozza, M; Farella, I; Laforgia, N; Panza, R | 1 |
1 review(s) available for phosphatidylcholines and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Lecithinized superoxide dismutase in the past and in the present: Any role in the actual pandemia of COVID-19?
Topics: Animals; Antioxidants; COVID-19; COVID-19 Drug Treatment; Humans; Multiple Organ Failure; Oxidative Stress; Pandemics; Phosphatidylcholines; Reactive Oxygen Species; Superoxide Dismutase | 2021 |
10 other study(ies) available for phosphatidylcholines and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Sex-dependent differences in stress-induced depression in Wistar rats are accompanied predominantly by changes in phosphatidylcholines and sphingomyelins.
Topics: Animals; COVID-19; Depression; Female; Humans; Male; Phosphatidylcholines; Pregnancy; Rats; Rats, Wistar; SARS-CoV-2; Sphingomyelins | 2021 |
Phosphatidic acid phosphatase 1 impairs SARS-CoV-2 replication by affecting the glycerophospholipid metabolism pathway.
Topics: Caco-2 Cells; Ceramides; COVID-19; Ethers; Glycerophospholipids; Humans; Lipid Metabolism; Phosphatidate Phosphatase; Phosphatidylcholines; Phosphatidylethanolamines; SARS-CoV-2 | 2022 |
Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19.
Topics: Animals; Biomarkers; Ceramides; COVID-19; Glycerophospholipids; Histones; Lipopolysaccharides; Lysophosphatidylcholines; Mice; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylglycerols; Phosphatidylinositols; Sphingolipids; Sphingomyelins; Thromboplastin | 2022 |
Lipidomics Revealed Plasma Phospholipid Profile Differences between Deceased and Recovered COVID-19 Patients.
Topics: Autoantibodies; COVID-19; Cyclooxygenase 2; Humans; Lipidomics; Lipoproteins, LDL; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylserines; Phospholipids | 2022 |
Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries.
Topics: Ceramides; COVID-19; Cross-Sectional Studies; Glycerophospholipids; Humans; Kidney; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylglycerols; Phosphatidylserines; Retrospective Studies; SARS-CoV-2; Sphingolipids; Sphingosine | 2022 |
Ionizable lipids penetrate phospholipid bilayers with high phase transition temperatures: perspectives from free energy calculations.
Topics: COVID-19; COVID-19 Vaccines; Humans; Lipid Bilayers; Phosphatidylcholines; Phospholipids; Phosphorylcholine; Transition Temperature | 2023 |
Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
Topics: Animals; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; DNA; Humans; Immunoglobulin M; Liposomes; Nanoparticles; Phosphatidylcholines; Polyethylene Glycols; Rats | 2023 |
Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
Topics: Aged; Aged, 80 and over; Amino Acids; Arachidonic Acid; Biomarkers; Citric Acid Cycle; Coronavirus Infections; COVID-19; Female; Gluconeogenesis; Humans; Male; Metabolome; Middle Aged; Oleic Acid; Pandemics; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipases A2; Pneumonia, Viral; Triglycerides | 2020 |
Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?
Topics: COVID-19; Cytokines; Disease Progression; Humans; Inflammation; Inositol; Interleukin-6; Lung; Phosphatidylcholines; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Prognosis; Respiratory Distress Syndrome; Signal Transduction; STAT3 Transcription Factor; Surface-Active Agents; X-Box Binding Protein 1 | 2020 |
Enhanced Cholesterol-Dependent Hemifusion by Internal Fusion Peptide 1 of SARS Coronavirus-2 Compared to Its N-Terminal Counterpart.
Topics: Amino Acid Sequence; Cholesterol; COVID-19; Humans; Membrane Fusion; Peptide Fragments; Phosphatidylcholines; SARS-CoV-2; Virus Internalization | 2021 |